Bazinaprine
Alternative Names: SR 91591Latest Information Update: 14 Aug 1996
At a glance
- Originator Sanofi-Synthelabo
- Class Antidepressants; Pyridazines; Small molecules
- Mechanism of Action Monoamine oxidase A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 14 Aug 1996 Discontinued-I for Depression in France (Unknown route)
- 14 Aug 1996 Discontinued-I for Depression in United Kingdom (Unknown route)